Jacobio Pharmaceuticals Group Investor Relations Material
Latest events
H2 2024
24 Apr, 2025
H1 2024
27 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jacobio Pharmaceuticals Group Co., Ltd.
Access all reports
Jacobio Pharmaceuticals Group Co., Ltd. is a Chinese biopharmaceutical company focused on innovative drug discovery and development. It concentrates on oncology and immunology, advancing a pipeline of targeted therapies and immune-oncology treatments. The company uses in-house research platforms and conducts clinical trials both domestically and internationally. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
1167
Country
🇭🇰 Hong Kong